Evidence map›Paper›PMID 31100460›Full record

ArticleClinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association2020

Liver Stiffness Severity is Associated With Increased Cardiovascular Risk in Patients With Type 2 Diabetes.

Neeraj Mangla, Veeral H Ajmera, Cyrielle Caussy, Claude Sirlin, Sharon Brouha, Sonia Bajwa-Dulai, Egburt Madamba, Ricki Bettencourt, Lisa Richards, Rohit Loomba

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed.

  1. Trial
  2. Review
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Review
  9. Review
  10. Article
  11. Review
  12. Article
  13. Review
  14. Review
  15. Article
  16. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Neeraj ManglaNAFLD Research Center, Department of Medicine, La Jolla, California.
Veeral H AjmeraNAFLD Research Center, Department of Medicine, La Jolla, California; Division of Gastroenterology, Department of Medicine, La Jolla, California.
Cyrielle CaussyNAFLD Research Center, Department of Medicine, La Jolla, California; Université Lyon 1, Hospices Civils de Lyon, Lyon, France.
Claude SirlinLiver Imaging Group, Department of Radiology, University of California at San Diego, La Jolla, California.
Sharon BrouhaLiver Imaging Group, Department of Radiology, University of California at San Diego, La Jolla, California.
Sonia Bajwa-DulaiNAFLD Research Center, Department of Medicine, La Jolla, California.
Egburt MadambaNAFLD Research Center, Department of Medicine, La Jolla, California.
Ricki BettencourtNAFLD Research Center, Department of Medicine, La Jolla, California.
Lisa RichardsNAFLD Research Center, Department of Medicine, La Jolla, California.
Rohit LoombaNAFLD Research Center, Department of Medicine, La Jolla, California; Liver Imaging Group, Department of Radiology, University of California at San Diego, La Jolla, California; Division of Epidemiology, Department of Family and Preventive Medicine, University of California at San Diego, La Jolla, California. Electronic address: roloomba@ucsd.edu.

Funding

UC San Diego Clinical and Translational Research InstituteUL1TR001442 · NCATS · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI FIRESTEIN, GARY S, HOGARTH, MICHAEL · 2015 to 2024
$88.3M
Yeast Genetics and Stress Response Genes-BiomedicalP42ES010337 · NIEHS · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI TUKEY, ROBERT H · 2000 to 2022
$69.8M
QUS Technology for Diagnosis and Grading of Hepatic Steatosis in NAFLDR01DK106419 · NIDDK · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI LOOMBA, ROHIT, SIRLIN, CLAUDE B · 2015 to 2019
$3.4M
A Novel Multimodal Approach to Characterize NAFLD Severity and PrognosisK23DK119460 · NIDDK · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI AJMERA, VEERAL HARESH · 2019 to 2023
$1.1M
GENETIC EPIDEMIOLOGY OF NONALCOHOLIC FATTY LIVER DISEASEK23DK090303 · NIDDK · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI LOOMBA, ROHIT · 2011 to 2014
$721k
NCATS NIH HHS UL1 TR001442NIDDK NIH HHS K23 DK090303NIDDK NIH HHS K23 DK119460NIDDK NIH HHS R01 DK106419NIEHS NIH HHS P42 ES010337
6 · The paper itself

Abstract

Cardiovascular disease (CVD) is the leading cause of death among patients with nonalcoholic fatty liver disease (NAFLD) and is strongly associated with type 2 diabetes mellitus (DM2).

Indexed as

Cardiovascular DiseasesDiabetes Mellitus, Type 2Elasticity Imaging TechniquesNon-alcoholic Fatty Liver DiseaseCross-Sectional StudiesHeart Disease Risk FactorsHumansLiverLiver CirrhosisRisk Factors

Identifiers

PMID31100460
PMCPMC6984972

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.